Table 2.
Defining level |
||
---|---|---|
Risk factor | NCEP proposals: any three features | IDF proposals: large waist plus two other features |
Large waist circumference | ||
Men | ≥102 cm (40 in) | ≥94 cm (37 in) |
Women | ≥88 cm (35 in) | ≥80 cm (32 in) |
Raised triglycerides | ≥1.7 mmol/L (150 mg/dL) | ≥1.7 mmol/L (150 mg/dL) |
Reduced HDL cholesterol | ||
Men | <1.03 mmol/L (40 mg/dL) | <1.03 mmol/L (40 mg/dL) |
Women | <1.29 mmol/L (50 mg/dL) | <1.29 mmol/L (50 mg/dL) |
Raised blood pressure | ≥130/≥85 mmHg | ≥130/≥85 mmHg |
Raised fasting plasma glucose | ≥6.1 mmol/L (110 mg/dL) | ≥5.6 mmol/L (100 mg/dL) |
Note: All individual components are below treatment thresholds, but combined in the metabolic syndrome, coronary heart disease risk is doubled. If body mass index ≥30 kg/m2 then assume waist circumference is above treatment level.